Angiodynamics to report fiscal 2022 second quarter financial results on january 6, 2022

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of fiscal year 2022 before the market open on thursday, january 6, 2022. the company's management will host a conference call at 8:00 a.m. et the same day to discuss the results. to participate in the conference call, dial
ANGO Ratings Summary
ANGO Quant Ranking